ReviewImmunological reviews2022

Immunogenicity and efficacy of Ad26.COV2.S: An adenoviral vector-based COVID-19 vaccine.

Mathieu Le Gars et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.